David Jensen

Writing from the perspective of more than three decades in the news business, Jensen brings a background in business and government to bear on the $3 billion California stem cell agency. Now retired, his career included a 10-year stint as executive business editor of The Sacramento Bee, legislative coverage for United Press International and two years as a press aide to Gov. Jerry Brown during his first term in office. Jensen has covered the stem cell agency since its inception from his sailboat/home located south of the border with visits to California from time to time.

Web Site: http://californiastemcellreport.blogspot.com/


Tracking California Stem Cell Awards: Diabetes to Dialysis

Jul 22, 2016

The California stem cell agency, as expected, yesterday pumped $10 million into a North Carolina firm for a kidney dialysis device and upped its stake in a San Diego diabetes therapy firm to $60 million.The awards were first reported (see here and here...

California Stem Cell Appeals: Zika, Parkinson’s and ‘Heart-on-a-Chip’

Jul 21, 2016
California Stem Cell Appeals: Zika, Parkinson’s and ‘Heart-on-a-Chip’

Three California researchers are asking the directors of the state's stem cell agency today to reject the decisions of its blue-ribbon scientific reviewers and grant them awards ranging up to $2 million.

The scientists are Alysson Muotri, director of the UC San Diego stem cell program; Birgitt Schuele, director of gene discovery and stem cell...

Search for a Diabetes Cure: California Stem Cell Agency Hits $60 Million Mark with ViaCyte

Jul 14, 2016


The California stem cell agency next week is slated to award  an additional $4 million to ViaCyte, Inc., a San Diego firm that is working with the agency to develop a "virtual" cure for diabetes.

ViaCyte has already received $56 million over the years from the California Institute for Regenerative Medicine(CIRM), as the agency is...

Text of ViaCyte’s Statement on its New Proposed Diabetes Product

Jul 14, 2016

The California Stem Cell Report this morning queried Paul Laikind, the CEO of ViaCyte, Inc., of San Diego, about the company's upcoming $4 million award from the California stem cell agency and the award's relationship to the ViaCyte product known as VC-01. Here is the text of his response.

"ViaCyte is continuing development of VC-01...

$10 Million California Stem Cell Award for Creation of a New ‘Lifeline" for Kidney Disease Patients

Jul 13, 2016
$10 Million California Stem Cell Award for Creation of a New ‘Lifeline" for Kidney Disease Patients


A 2014 interview with Laura Niklason, whose firm, Humacyte, will receive a $10 million award from California. The interview was conducted at the Stem Cells Meeting on the Mesa in La Jolla, Ca.

Highlights
$10 million matched by Humacyte
Three clinical trial locations in California
Humacyte raised $150 million last year

The California stem cell agency is set to...

More Than a Minor Headache: The Stem Cell Snake Oil Problem vs. Legitimate Research

Jul 11, 2016

Just two weeks ago, the headlines from Bloomberg News offered a glowing view of the prospects for stem cell therapies and the industry. The story in the online publication, which counts nearly 9 million readers monthly, said,"Stem cell crusader sparks ...

A Scientist’s Comment: Deal Directly with FDA Rather Criticizing It in the Media

Jul 10, 2016

The following comment on FDA regulation of stem cell research was submitted via email by a longtime scientist in the field, who asked to remain anonymous. 
"Many advertised  'stem cell' treatments use hematopoietic or blood stem cells which are run under a different set of regulations from pluripotent stem cells since they are...

Monty Python, $3 billion and Stem Cells in the Golden State

Jul 7, 2016
Monty Python, $3 billion and Stem Cells in the Golden State

Inquisition scene from Monty Python, photo CIRM/Daily Mail
The headline today from California was nearly irresistible:
"The Spanish Inquisition and a tale of two stem cell agencies"
Not only that, but the headline appeared over an article involving Monty Python, the $3 billion California stem cell agency and the lesser,...

Influential Scientific Journal Rips Effort to Loosen Stem Cell Research Rules

Jul 5, 2016

The prestigious journal Nature today editorialized against easing federal regulation of stem cell treatments, a major blow to the campaign by the California stem cell agency to speed such therapies to the marketplace.

The headline on the piece said,

"FDA should stand firm on stem cell treatments."
The unsigned editorial declared that those who contend...

‘False Hopes, Sizable Profits’ — The Nation’s Largely Unregulated Stem Cell Clinics

Jul 1, 2016
‘False Hopes, Sizable Profits’ — The Nation’s Largely Unregulated Stem Cell Clinics

Locations of stem cell clinics identified in Knoepfler/Turner study
Graphic by Cell Stem Cell 
The biggest stem cell story in the country this week reported that at least 570 dubious stem cell clinics exist throughout the nation that could pose a danger to both the pocketbooks and health...

Stay connected to Sacramento Connect

Follow Sacramento Connect on Twitter  Find Sacramento Connect on Facebook

Categories

  • Hot Topics (2)
  • Shopping (1048)
  • Top Stories (3614)


Newest Partners